
From the U.S. Code Online via GPO Access
[wais.access.gpo.gov]
[Laws in effect as of January 23, 2000]
[Document not affected by Public Laws enacted between
  January 23, 2000 and December 4, 2001]
[CITE: 42USC300b-1]

 
                 TITLE 42--THE PUBLIC HEALTH AND WELFARE
 
                    CHAPTER 6A--PUBLIC HEALTH SERVICE
 
SUBCHAPTER IX--GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT 
                             DEATH SYNDROME
 
                        Part A--Genetic Diseases
 
Sec. 300b-1. Research project grants and contracts

    In carrying out section 241 of this title, the Secretary may make 
grants to public and nonprofit private entities, and may enter into 
contracts with public and private entities and individuals, for projects 
for (1) basic or applied research leading to the understanding, 
diagnosis, treatment, and control of genetic diseases, (2) planning, 
establishing, demonstrating, and developing special programs for the 
training of genetic counselors, social and behavioral scientists, and 
other health professionals, (3) the development of programs to educate 
practicing physicians, other health professionals, and the public 
regarding the nature of genetic processes, the inheritance patterns of 
genetic diseases, and the means, methods, and facilities available to 
diagnose, control, counsel, and treat genetic diseases, and (4) the 
development of counseling and testing programs and other programs for 
the diagnosis, control, and treatment of genetic diseases. In making 
grants and entering into contracts for projects described in clause (1) 
of the preceding sentence, the Secretary shall give priority to 
applications for such grants or contracts which are submitted for 
research on sickle cell anemia and for research on Cooley's anemia.

(July 1, 1944, ch. 373, title XI, Sec. 1102, as added Pub. L. 94-278, 
title IV, Sec. 403(a), Apr. 22, 1976, 90 Stat. 408.)


                            Prior Provisions

    A prior section 300b-1, act July 1, 1944, ch. 373, title XI, 
Sec. 1102, as added May 16, 1972, Pub. L. 92-294, Sec. 3(c), 86 Stat. 
138, authorized Secretary to make grants and enter contracts with public 
and private entities and individuals for projects concerned with 
research, research training in diagnosis, treatment and control of 
sickle cell anemia, informational and educational programs with respect 
to sickle cell anemia and development of counseling and testing 
programs, prior to the general amendment of this part by Pub. L. 94-278 
and is covered by this section.


                             Effective Date

    Section 403(c) of Pub. L. 94-278 provided that: ``The amendments 
made by subsections (a) and (b) [see section 401 of Pub. L. 94-278, set 
out as a Short Title of 1976 Amendment note under section 201 of this 
title] shall take effect July 1, 1976.''


                      Short Title of 1976 Amendment

    For short title of title IV of Pub. L. 94-278, which enacted this 
part, omitted former part B of this subchapter, redesignated former 
parts C and D of this subchapter as parts B and C of this subchapter, 
respectively, as the ``National Sickle Cell Anemia, Cooley's Anemia, 
Tay-Sachs, and Genetic Diseases Act'', see section 401 of Pub. L. 94-
278, set out as a note under section 201 of this title.


                  Congressional Declaration of Purpose

    Section 402 of Pub. L. 94-278, as amended by Pub. L. 95-626, title 
II, Sec. 205(a), Nov. 10, 1978, 92 Stat. 3583, provided that: ``In order 
to preserve and protect the health and welfare of all citizens, it is 
the purpose of this title [see section 401 of Pub. L. 94-278, set out as 
a Short Title of 1976 Amendment note under section 201 of this title] to 
establish a national program to provide for basic and applied research, 
research training, testing, counseling, and information and education 
programs with respect to genetic diseases, and genetic conditions, such 
as Sickle Cell anemia, Cooley's Anemia, Tay-Sachs disease, cystic 
fibrosis, dysautonomia, hemophilia, retinitis pigmentosa, Huntington's 
chorea, muscular dystrophy, and genetic conditions leading to mental 
retardation or genetically caused mental disorders.''

                  Section Referred to in Other Sections

    This section is referred to in section 300b-3 of this title.
